Bioventus launched DUROLANE® single-injection joint fluid therapy in Mexico, indicated for treatment of mild to moderate knee osteoarthritis. The product will be distributed by Artimedica.
The company now markets orthobiologic solutions in >29 countries.
Bioventus launched DUROLANE® single-injection joint fluid therapy in Mexico, indicated for treatment of mild to moderate knee osteoarthritis. The product will be distributed by Artimedica.
The company now markets orthobiologic solutions in...
Bioventus launched DUROLANE® single-injection joint fluid therapy in Mexico, indicated for treatment of mild to moderate knee osteoarthritis. The product will be distributed by Artimedica.
The company now markets orthobiologic solutions in >29 countries.
Copy to clipboard 
